Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2020. Go to the latest filing (Q3 2026)

11.8B USDQ1 2020
Total value of stock positions
11.8B USD
Positions
713
Share of the ten largest
15.6%

The ten largest positions Q1 2020

  1. Amazon 2.9%▼ −10.3%
  2. Micron Technology 2.2%▲ +229.9%
  3. JD.com (ADR) 1.9%▼ −15.7%
  4. NXP Semiconductors 1.5%▲ +12.1%
  5. United Technologies Corp 1.3%▲ +34.5%
  6. Fidelity National Information Services 1.3%▼ −40.0%
  7. Alibaba Group (ADR) 1.2%▼ −40.4%
  8. Las Vegas Sands 1.1%▲ +202.2%
  9. Dollar General 1.1%▼ −24.1%
  10. Take-Two Interactive 1.1%new
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q1 2020

Positions Q1 2020 per 13F filing, 50 of 205
Symbol Weight Shares Reported value Change Held since
MU Micron Technology 2.2% 6,206,425 261.0M USD +229.9% increased Q2 2019 4 quarters
NXPI NXP Semiconductors 1.5% 2,203,767 182.8M USD +12.1% increased Q3 2018 7 quarters
United Technologies Corp 1.3% 1,659,347 156.5M USD +34.5% increased Q1 2017 13 quarters
LVS Las Vegas Sands 1.1% 3,141,220 133.4M USD +202.2% increased Q3 2018 7 quarters
BNY BNY Mellon 1.0% 3,540,406 119.2M USD +110.3% increased Q3 2019 3 quarters
BIDU Baidu (ADR) 1.0% 1,152,826 116.2M USD +9.2% increased Q3 2019 3 quarters
CSX CSX Corporation 0.9% 1,927,831 110.5M USD +1,682.4% increased Q3 2019 3 quarters
CVX Chevron Corporation 0.8% 1,289,029 93.4M USD +57.8% increased Q4 2019 2 quarters
BAX Baxter International 0.8% 1,143,154 92.8M USD +995.2% increased Q2 2019 4 quarters
IOVA Iovance Biotherapeutics 0.8% 3,065,226 91.8M USD +9.3% increased Q2 2019 4 quarters
EL Estée Lauder Companies (The) 0.7% 544,846 86.8M USD +3.5% increased Q2 2018 8 quarters
Mgic Invt Corp Wis 0.7% 13,218,651 83.9M USD +167.7% increased Q1 2018 9 quarters
Mgm Growth Pptys LLC 0.6% 2,990,344 70.8M USD +1,109.7% increased Q3 2019 3 quarters
PGR Progressive Corporation 0.6% 957,297 70.7M USD +132.6% increased Q4 2018 6 quarters
CHTR Charter Communications 0.6% 160,205 69.9M USD +5,046.3% increased Q4 2019 2 quarters
Aurinia Pharmaceuticals Inc 0.6% 4,669,343 67.8M USD +29.9% increased Q1 2019 5 quarters
Equinor ASA 0.5% 5,274,673 64.2M USD +23.6% increased Q1 2019 5 quarters
ZTS Zoetis 0.5% 542,682 63.9M USD +654.8% increased Q2 2019 4 quarters
Vale S A 0.5% 7,665,190 63.5M USD +150.2% increased Q2 2019 4 quarters
Dynatrace Inc 0.5% 2,655,419 63.3M USD +541.0% increased Q4 2019 2 quarters
Renaissancere Holdings Ltd 0.5% 421,796 63.0M USD +251.5% increased Q2 2019 4 quarters
DUK Duke Energy 0.5% 757,051 61.2M USD +103.3% increased Q4 2019 2 quarters
Alexion Pharmaceuticals Inc 0.5% 642,345 57.7M USD +89.8% increased Q2 2019 4 quarters
COF Capital One 0.5% 1,122,945 56.6M USD +44.3% increased Q3 2015 19 quarters
MS Morgan Stanley 0.5% 1,633,500 55.5M USD +989.0% increased Q1 2018 9 quarters
Mks Instrs Inc 0.5% 680,924 55.5M USD +41.6% increased Q1 2019 5 quarters
Insmed Inc 0.5% 3,328,676 53.4M USD +1,282.1% increased Q3 2018 7 quarters
Constellation Pharmceticls I 0.4% 1,526,975 48.0M USD +204.9% increased Q4 2019 2 quarters
LYV Live Nation Entertainment 0.4% 1,046,701 47.6M USD +69.0% increased Q2 2019 4 quarters
NOC Northrop Grumman 0.4% 149,606 45.3M USD +36.4% increased Q1 2019 5 quarters
Encompass Health Corp 0.4% 680,254 43.6M USD +16.1% increased Q4 2018 6 quarters
SYF Synchrony Financial 0.4% 2,676,125 43.1M USD +57.5% increased Q3 2018 7 quarters
Ferrari N V 0.4% 280,578 42.8M USD +124.1% increased Q1 2019 5 quarters
Total S.a. 0.4% 1,148,250 42.8M USD +267.4% increased Q3 2017 11 quarters
DRI Darden Restaurants 0.4% 782,742 42.6M USD +61.2% increased Q4 2019 2 quarters
HCA HCA Healthcare 0.4% 472,610 42.5M USD +158.2% increased Q4 2017 10 quarters
C Citigroup 0.3% 968,300 40.8M USD +423.7% increased Q4 2018 6 quarters
Mimecast Ltd 0.3% 1,153,056 40.7M USD +53.4% increased Q4 2019 2 quarters
DE Deere & Company 0.3% 287,290 39.7M USD +14.5% increased Q3 2019 3 quarters
ROP Roper Technologies 0.3% 125,485 39.1M USD +10.9% increased Q4 2017 10 quarters
SPGI S&P Global 0.3% 157,187 38.5M USD +20.5% increased Q1 2019 5 quarters
Zynga Inc 0.3% 5,576,693 38.2M USD +64.0% increased Q4 2018 6 quarters
L Brands Inc 0.3% 3,263,851 37.7M USD +82.6% increased Q2 2019 4 quarters
FISV Fiserv 0.3% 374,703 35.6M USD +214.1% increased Q4 2019 2 quarters
First Bancorp P R 0.3% 6,650,115 35.4M USD +387.4% increased Q1 2015 21 quarters
VIPS Vipshop 0.3% 2,259,624 35.2M USD +26.5% increased Q3 2019 3 quarters
EXPE Expedia Group 0.3% 617,226 34.7M USD +64.3% increased Q4 2019 2 quarters
INCY Incyte 0.3% 465,161 34.1M USD +824.8% increased Q4 2019 2 quarters
Advance Auto Parts Inc 0.3% 361,279 33.7M USD +47.9% increased Q2 2018 8 quarters
CRL Charles River Laboratories 0.3% 260,500 32.9M USD +66.1% increased Q2 2019 4 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 largest of 205 positions.

Plus 32 option positions, value of the underlying shares as reported 481.6M USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 191.1M USD
  • Ptc Therapeutics Inc Call 42.4M USD
  • Citigroup Call 42.1M USD
  • Biogen Call 22.0M USD
  • Momenta Pharmaceuticals Inc Call 16.3M USD
  • Ishares TR Put 15.9M USD
  • Capital One Call 12.6M USD
  • Seattle Genetics Inc Call 11.5M USD
  • Iovance Biotherapeutics Call 10.8M USD
  • Nike, Inc. Call 10.3M USD

Breakdown by sector

  • Technology 12.1%
  • Financials 9.3%
  • Consumer Discretionary 7.6%
  • Industrials 6.1%
  • Health Care 6.1%
  • Consumer Staples 4.4%
  • Communication Services 2.1%
  • Energy 2.0%
  • Utilities 1.6%
  • Real Estate 1.3%
  • Materials 1.1%
  • not in our coverage 46.3%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close